First American Bank’s Regulus Therapeutics RGLS Stock Holding History

First American Bank's RGLS Position: Q2 2016 in Review

First American Bank sold out of Regulus Therapeutics (RGLS) in Q2 2016, closing a stake of 289 shares — an estimated $240K sold.

First American Bank first reported a position in RGLS in Q4 2014 and held it in 5 quarters. The position peaked at $281K in Q4 2015. 83 funds tracked by Wall St. Rank hold RGLS as of Q2 2016.

• First American Bank reported no remaining Regulus Therapeutics position as of Q2 2016 after selling out during the quarter.
• First American Bank sold 289 Regulus Therapeutics shares in Q2 2016, an estimated $240K.
• First American Bank first reported a position in Regulus Therapeutics in Q4 2014 and held it in 5 quarters.
• First American Bank's Regulus Therapeutics position peaked at $281K in Q4 2015.
• 83 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q2 2016.

Based on First American Bank's 13F filing for Q2 2016, filed 20 Jul 2016.